secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 75328 grounded facts newest July 10, 2026, 5:10 PM ET RSS · JSON

Showing 2701–2750 of 75328

Departed

Christopher W. Silcock

President, Global Brands & Commercial Services
HLT · Hilton Worldwide Holdings Inc.
Effective
2027-03-31
Filed
May 5, 2026, 7:59 PM ET
Christopher W. Silcock, President, Global Brands & Commercial Services, intends to retire from the Company in the first quarter of 2027.
Role change

Laura Fuentes

Chief Brand Officer
HLT · Hilton Worldwide Holdings Inc.
Filed
May 5, 2026, 7:59 PM ET
Laura Fuentes, Executive Vice President, Chief Human Resources Officer and Head of Hilton Supply Management, will move to the role of Chief Brand Officer;
Appointed

Chris Wilroy

Executive Committee
HLT · Hilton Worldwide Holdings Inc.
Filed
May 5, 2026, 7:59 PM ET
Chris Wilroy, Chief Commercial Officer, will join the Executive Committee;
Departed

Radhika Tripuraneni

Director
TERN · Terns Pharmaceuticals, Inc.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
each of Robert Azelby, Amy Burroughs, David Fellows, Jeffrey B. Kindler, J.D., Jill M. Quigley, J.D., Radhika Tripuraneni, M.D. and Heather Turner, J.D. ceased to be a member of the Board of Directors of Terns
Departed

Jill M. Quigley

Director
TERN · Terns Pharmaceuticals, Inc.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
each of Robert Azelby, Amy Burroughs, David Fellows, Jeffrey B. Kindler, J.D., Jill M. Quigley, J.D., Radhika Tripuraneni, M.D. and Heather Turner, J.D. ceased to be a member of the Board of Directors of Terns
Departed

Jeffrey B. Kindler

Director
TERN · Terns Pharmaceuticals, Inc.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
each of Robert Azelby, Amy Burroughs, David Fellows, Jeffrey B. Kindler, J.D., Jill M. Quigley, J.D., Radhika Tripuraneni, M.D. and Heather Turner, J.D. ceased to be a member of the Board of Directors of Terns
Appointed

Melissa Leonard

Director
TERN · Terns Pharmaceuticals, Inc.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the directors of Purchaser as of immediately prior to the Effective Time, which consisted of Jon Filderman, Melissa Leonard and Dalton Smart, became the directors of the Surviving Corporation.
Departed

Amy Burroughs

Director
TERN · Terns Pharmaceuticals, Inc.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
each of Robert Azelby, Amy Burroughs, David Fellows, Jeffrey B. Kindler, J.D., Jill M. Quigley, J.D., Radhika Tripuraneni, M.D. and Heather Turner, J.D. ceased to be a member of the Board of Directors of Terns
Departed

Heather Turner

Director
TERN · Terns Pharmaceuticals, Inc.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
each of Robert Azelby, Amy Burroughs, David Fellows, Jeffrey B. Kindler, J.D., Jill M. Quigley, J.D., Radhika Tripuraneni, M.D. and Heather Turner, J.D. ceased to be a member of the Board of Directors of Terns
Departed

David Fellows

Director
TERN · Terns Pharmaceuticals, Inc.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
each of Robert Azelby, Amy Burroughs, David Fellows, Jeffrey B. Kindler, J.D., Jill M. Quigley, J.D., Radhika Tripuraneni, M.D. and Heather Turner, J.D. ceased to be a member of the Board of Directors of Terns
Departed

Robert Azelby

Director
TERN · Terns Pharmaceuticals, Inc.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
each of Robert Azelby, Amy Burroughs, David Fellows, Jeffrey B. Kindler, J.D., Jill M. Quigley, J.D., Radhika Tripuraneni, M.D. and Heather Turner, J.D. ceased to be a member of the Board of Directors of Terns
Appointed

Jon Filderman

Director
TERN · Terns Pharmaceuticals, Inc.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the directors of Purchaser as of immediately prior to the Effective Time, which consisted of Jon Filderman, Melissa Leonard and Dalton Smart, became the directors of the Surviving Corporation.
Appointed

Dalton Smart

Director
TERN · Terns Pharmaceuticals, Inc.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the directors of Purchaser as of immediately prior to the Effective Time, which consisted of Jon Filderman, Melissa Leonard and Dalton Smart, became the directors of the Surviving Corporation.
Role change (interim)

Mimi E. Vaughn

President, Chief Executive Officer, Interim Chief Financial Officer and principal financial officer
GCO · GENESCO INC
Effective
2026-04-30
Successor
Ashley Randolph
Filed
May 5, 2026, 7:59 PM ET
As such, as of the Effective Date, Ms. Vaughn will no longer serve as the Company’s principal accounting officer.
Appointed

Ashley Randolph

Chief Accounting Officer and principal accounting officer
GCO · GENESCO INC
Effective
2026-04-30
Filed
May 5, 2026, 7:59 PM ET
On May 5, 2026, Genesco Inc. (the “Company”) announced the appointment of Ashley Randolph as Chief Accounting Officer and principal accounting officer.
Appointed

Larry Kellerman

Director
FRMI · Fermi Inc.
Effective
2026-05-04
Filed
May 5, 2026, 7:59 PM ET
the board of directors of the Company (the “Board”) elected effective as of May 4, 2026, Mr. Larry Kellerman, the Chief Power Officer of the Company, to the Board to fill the vacancy created by Mr. Neugebauer’s previously announced departure from the Board.
Appointed

Larry Kellerman

Chief Power Officer
FRMI · Fermi Inc.
Effective
2026-05-04
Filed
May 5, 2026, 7:59 PM ET
the board of directors of the Company (the “Board”) elected effective as of May 4, 2026, Mr. Larry Kellerman, the Chief Power Officer of the Company, to the Board to fill the vacancy created by Mr. Neugebauer’s previously announced departure from the Board.
Appointed

Sungjoon Chae

Co-Chief Executive Officer
APUS · Apimeds Pharmaceuticals US, Inc.
Effective
2026-05-04
Filed
May 5, 2026, 7:59 PM ET
On May 4, 2026, pursuant to a nomination by a stockholder of Apimeds Pharmaceuticals US, Inc., a Delaware corporation (the " Company "), the board of directors of the Company (the " Board ") appointed Sungjoon Chae to serve as Co-Chief Executive Officer of the Company, effective as of such date.
Appointed

Tengku Dato' Musahiddin Shah Bin Tengku Dato' Seri Samad Shah Alhaj

non-executive director
TGL · TREASURE GLOBAL INC
Effective
2026-05-01
Filed
May 5, 2026, 7:59 PM ET
On May 1, 2026, Tengku Dato’ Musahiddin Shah Bin Tengku Dato’ Seri Samad Shah Alhaj was appointed as a non-executive director of the Board.
Departed

Chan Wai Kuan

non-executive director
TGL · TREASURE GLOBAL INC
Effective
2026-05-01
Successor
Tengku Dato' Musahiddin Shah Bin Tengku Dato' Seri Samad Shah Alhaj
Filed
May 5, 2026, 7:59 PM ET
On May 1, 2026, Mr. Chan Wai Kuan informed Treasure Global Inc. (the “Company”) of his resignation as non-executive director of the board of the directors of the Company (“the Board”), which was immediately effective.
Appointed

Eric Stone

Class I director
CEPS · Cantor Equity Partners VI, Inc.
Effective
2026-04-30
Filed
May 5, 2026, 7:59 PM ET
Effective April 30, 2026, the board of directors (the “ Board ”) of Cantor Equity Partners VI, Inc. (the “ Company ”) appointed Eric Stone as a member of the Board.
Appointed

Moishe Gubin

Chief Executive Officer and principal executive officer
OPHC · OptimumBank Holdings, Inc.
Effective
2026-05-01
Filed
May 5, 2026, 7:59 PM ET
Effective the same date: (i) the Company appointed its Chairman of the Board, Moishe Gubin, as its Chief Executive Officer and principal executive officer; and (ii) the Bank appointed Mr. Gubin as its Chief Executive Officer.
Appointed

Braden R. Smith

President
OPHC · OptimumBank Holdings, Inc.
Effective
2026-05-01
Filed
May 5, 2026, 7:59 PM ET
Also effective the same date, the Bank appointed Braden R. Smith as its President.
Departed

Timothy Terry

principal executive officer, President and Chief Executive Officer
OPHC · OptimumBank Holdings, Inc.
Effective
2026-05-01
Successor
Moishe Gubin
Filed
May 5, 2026, 7:59 PM ET
On May 1, 2026, Timothy Terry retired as principal executive officer of OptimumBank Holdings, Inc. (the “Company”) and as President and Chief Executive Officer of its wholly-owned subsidiary, OptimumBank.
Appointed

Ying Cenly Chen

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
Appointed

Douglas Miller

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
Appointed

William M. Clancy

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
Appointed

Scott G. Davis

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
Appointed

Richard Nottenburg

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
Departed

Mary Ann Cloyd

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher
Appointed

Ella Benson

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
Departed

Charles Li

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher
Departed

Corinna Lathan

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher
Departed

Deborah Lafer Scher

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher
Appointed

Wes Cummins

Chairman of the Board
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
Appointed

Christopher Wiernicki

Class I director
LPG · DORIAN LPG LTD.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
appointed Christopher Wiernicki to serve as a Class I director
Appointed

Daniel McFadden

Chief Operating Officer
AHCO · AdaptHealth Corp.
Effective
2026-05-04
Filed
May 5, 2026, 7:59 PM ET
Also on May 4, 2026, the Company appointed Daniel McFadden, the Company’s current Chief Business Systems Officer, as the Company’s Chief Operating Officer.
Departed

Toby Scott Barnhart

Chief Operating Officer
AHCO · AdaptHealth Corp.
Effective
2026-05-04
Successor
Daniel McFadden
Filed
May 5, 2026, 7:59 PM ET
On May 4, 2026, the Company terminated the employment of Toby Scott Barnhart, the Company’s Chief Operating Officer.
Departed

Gregory P. Giometti

Interim Chief Financial Officer
ALIT · Alight, Inc. / Delaware
Effective
2026-05-08
Successor
Susan D. Davies
Filed
May 5, 2026, 7:59 PM ET
On February 27, 2026, the Company announced that Gregory P. Giometti, the Company’s Interim Chief Financial Officer, would depart the Company on May 8, 2026
Appointed (interim)

Susan D. Davies

Interim Chief Financial Officer
ALIT · Alight, Inc. / Delaware
Effective
2026-05-08
Filed
May 5, 2026, 7:59 PM ET
on April 30, 2026, the Company’s Board of Directors appointed Susan D. Davies, who currently serves as the Company’s Chief Accounting Officer and Global Controller, to serve as Interim Chief Financial Officer, effective as of May 8, 2026
Appointed

Jorge Ray

Principal Accounting Officer
CORZ · Core Scientific, Inc./tx
Effective
2026-05-07
Filed
May 5, 2026, 7:59 PM ET
On April 30, 2026, the Board of Directors of Core Scientific, Inc. (the “Company”) appointed Jorge Ray as the Company’s Principal Accounting Officer, effective May 7, 2026.
Role change (interim)

Nelson Urdaneta

Senior Vice President and Chief Financial Officer
KMB · KIMBERLY CLARK CORP
Effective
2026-05-22
Filed
May 5, 2026, 7:59 PM ET
The Corporation’s Senior Vice President and Chief Financial Officer, Nelson Urdaneta, will act as the Corporation’s principal accounting officer effective upon Mr. Scribner’s departure on an interim basis and in addition to his current duties.
Departed

Andrew Scribner

Vice President and Controller
KMB · KIMBERLY CLARK CORP
Effective
2026-05-22
Successor
Nelson Urdaneta
Filed
May 5, 2026, 7:59 PM ET
On May 1, 2026, Andrew Scribner, the Corporation’s Vice President and Controller, notified the Corporation that he will depart the Corporation effective May 22, 2026 to pursue other opportunities.
Appointed

Ryan Sedlak

Executive Vice President, North America and Global Business Units
ENR · ENERGIZER HOLDINGS, INC.
Effective
2026-10-01
Filed
May 5, 2026, 7:59 PM ET
Ryan Sedlak, who currently serves as the Company’s Vice President, Global Finance & Analytics, will succeed Mr. Lampman as Executive Vice President, North America and Global Business Units, effective October 1, 2026.
Departed

Michael A. Lampman

Executive Vice President, North America and Global Business Units
ENR · ENERGIZER HOLDINGS, INC.
Effective
2026-09-30
Successor
Ryan Sedlak
Filed
May 5, 2026, 7:59 PM ET
Mr. Lampman will cease to serve as the Company’s Executive Vice President, North America and Global Business Units effective September 30, 2026
Departed

Diane Schnupp

Executive Vice President and Chief Information Officer
KNSL · Kinsale Capital Group, Inc.
Effective
2026-04-29
Filed
May 5, 2026, 7:59 PM ET
As previously disclosed, on April 29, 2026, Kinsale Capital Group, Inc. (the “Company”) announced Diane Schnupp’s retirement from her role as Executive Vice President and Chief Information Officer of the Company, effective April 29, 2026.
Appointed

Simon Kiero-Watson

Director
EDGM · Edgemode, Inc.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
On May 5, 2026, the Board of Directors (the “Board”) of Edgemode, Inc. (the “Company”), in accordance with the Company’s bylaws, appointed Simon Kiero-Watson to fill the vacancy on the Board created by a prior director’s resignation from the Board in September 2025.
Appointed

Austin Kaplicer

Principal Accounting Officer
ANGI · Angi Inc.
Effective
2026-05-04
Filed
May 5, 2026, 7:59 PM ET
Appointment of Principal Accounting Officer On May 4, 2026, Mr. Austin Kaplicer w
Role change

Michael Wanderer

Chief Operating Officer
ANGI · Angi Inc.
Effective
2026-05-04
Filed
May 5, 2026, 7:59 PM ET
On May 4, 2026, Mr. Michael Wanderer was appointed as Chief Operating Officer of Angi.
Role change

Michael B. Petras, Jr.

Executive Chairman of the Board
SHC · Sotera Health Co
Effective
2026-05-26
Filed
May 5, 2026, 7:59 PM ET
the Board appointed Mr. Petras to serve as Executive Chairman of the Board ("Executive Chairman"), as of the Effective Date.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.